Consolidated Statement of Income
|In millions of euros|
|Cost of sales||5||-134,295||-129,626|
|General administrative expenses||5||-4,036||-3,808|
|Research and non-capitalized development costs||5||-6,581||-5,938|
|Other operating income||6||2,330||2,259|
|Other operating expense||6||-1,462||-1,043|
|Profit on equity-method investments, net||13||656||1,498|
|Other financial income/expense, net||7||210||-210|
|Profit before income taxes 2||10,595||13,967|
|thereof profit attributable to non-controlling interests||333||339|
|thereof profit attributable to shareholders of ||7,249||10,278|
|Earnings per share (in euros)||36|
1 The prior-year figures have been adjusted due to the effects of the first-time adoption of IFRS 15 and IFRS 9.
Information on adjustments to prior-year figures is disclosed in Note 1 of the Notes to the Consolidated Financial Statements.
2 The reconciliation of Group EBIT to profit before income taxes is presented in Note 34.